#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1176088	F	Antidiabetic activity in db/db mouse assessed as weight gain at 10 to 100 mg/kg, po qd for 7 days	Mus musculus	1		organism-based format	Scientific Literature
2.	ALA1176089	F	Antidiabetic activity in db/db mouse assessed as reduction of plasma glucose level at 100 mg/kg, po qd for 7 days	Mus musculus	1		organism-based format	Scientific Literature
3.	ALA1176090	F	Antidiabetic activity in db/db mouse assessed as reduction of plasma glucose level at 30 mg/kg, po qd for 7 days	Mus musculus	1		organism-based format	Scientific Literature
4.	ALA1176091	F	Antidiabetic activity in db/db mouse assessed as reduction of plasma glucose level at 10 mg/kg, po qd for 7 days	Mus musculus	2		organism-based format	Scientific Literature
5.	ALA1176092	A	Oral bioavailability in mouse at 1 mg/kg	Mus musculus	1		organism-based format	Scientific Literature
6.	ALA1176093	A	AUC in mouse at 1 mg/kg, iv	Mus musculus	1		organism-based format	Scientific Literature
7.	ALA1176094	A	Half life in mouse at 1 mg/kg, iv	Mus musculus	1		organism-based format	Scientific Literature
8.	ALA1176095	A	Volume of distribution in mouse at 1 mg/kg, iv	Mus musculus	1		organism-based format	Scientific Literature
9.	ALA1176096	A	Clearance in mouse at 1 mg/kg, iv	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA1176097	A	Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in lipid accumulation after 7 days by Oil red O staining	Mus musculus	2		cell-based format	Scientific Literature
11.	ALA1176098	A	Induction of adipogenesis in mouse mature 3T3L1 cells assessed as P2 mRNA expression level after 10 days by Oil red O staining	Mus musculus	2		cell-based format	Scientific Literature
12.	ALA1176099	F	Antagonist activity at rat PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as inhibition of rosiglitazone-induced luciferase activity by transactivation assay	Rattus norvegicus	1		cell-based format	Scientific Literature
13.	ALA1176100	F	Antagonist activity at human PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as inhibition of rosiglitazone-induced luciferase activity by transactivation assay	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA1176101	A	Induction of adipogenesis in mouse blast 3T3L1 cells assessed as P2 mRNA expression level after 7 days by Oil red O staining	Mus musculus	2		cell-based format	Scientific Literature
15.	ALA1176102	F	Partial agonist activity at rat PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as luciferase activity by transactivation assay relative to rosiglitazone	Rattus norvegicus	1		cell-based format	Scientific Literature
16.	ALA1176103	F	Partial agonist activity at mouse PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as luciferase activity by transactivation assay relative to rosiglitazone	Mus musculus	1		cell-based format	Scientific Literature
17.	ALA1176104	F	Partial agonist activity at rat PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as luciferase activity by transactivation assay	Rattus norvegicus	1		cell-based format	Scientific Literature
18.	ALA1176105	P	Solubility in water		2		small-molecule physicochemical format	Scientific Literature
19.	ALA1176107	F	Partial agonist activity at human PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as luciferase activity by transactivation assay relative to rosiglitazone	Homo sapiens	21		cell-based format	Scientific Literature
20.	ALA1176108	F	Partial agonist activity at human PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as luciferase activity by transactivation assay	Homo sapiens	22		cell-based format	Scientific Literature